RAPT Therapeutics Inc
RAPT
Market Cap$139.4M
Close$
$4.05
44.7% downside
Current Fair Value
44.7% downsideOvervalued by 44.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $139.40 Million |
|---|---|
| Enterprise Value | $82.98 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-3.19 |
| Beta | -0.14 |
| Outstanding Shares | 53,852,563 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -3.9 |
|---|---|
| PEG | 8.9 |
| Price to Sales | - |
| Price to Book Ratio | 2.44 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.68 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About RAPT Therapeutics Inc
CEO: Brian Wong